Latest Articles

  • In reply: How should diabetic dyslipidemia be treated?
    Ting-I Lee, MD, PhD
    Cleveland Clinic Journal of Medicine January 2020, 87 (1) 11; DOI: https://doi.org/10.3949/ccjm.87c.01004
  • Are we all clear? Unintended shocks to caregivers during cardiopulmonary resuscitation
    David R. Lowery, MD, FASA, Maj, MC, USA, Daniel Cantillon, MD, FACC, FHRS and Donn Marciniak, MD
    Cleveland Clinic Journal of Medicine January 2020, 87 (1) 16-18; DOI: https://doi.org/10.3949/ccjm.87a.19022

    Defibrillators are designed to affect electrical activity in the patient’s heart. Caregivers, be careful!

  • Modifying genetic diseases: Promises to be realized?
    Brian F. Mandell, MD, PhD
    Cleveland Clinic Journal of Medicine January 2020, 87 (1) 7-8; DOI: https://doi.org/10.3949/ccjm.87b.01020

    Genetic engineering offers hope to patients and families who previously had little.

  • Sickle cell disease: A primary care update
    Grace Onimoe, MD and Seth Rotz, MD
    Cleveland Clinic Journal of Medicine January 2020, 87 (1) 19-27; DOI: https://doi.org/10.3949/ccjm.87a.18051

    Survival has improved, but patients still face multiorgan damage, chronic anemia, and debilitating pain crises.

  • Cardio-obstetrics: Recognizing and managing cardiovascular complications of pregnancy
    Cardio-obstetrics: Recognizing and managing cardiovascular complications of pregnancy
    Kayle S. Shapero, MD, PhD, Nihar R. Desai, MD, MPH, Robert W. Elder, MD, Heather S. Lipkind, MD, Josephine C. Chou, MD, MS and Erica S. Spatz, MD, MHS
    Cleveland Clinic Journal of Medicine January 2020, 87 (1) 43-52; DOI: https://doi.org/10.3949/ccjm.87a.18137

    Pregnancy can exacerbate known cardiovascular disorders and unmask previously unrecognized problems.

  • In reply: Is diabetes still a compelling indication for renin-angiotensin-aldosterone system inhibitors?
    Sunil Bhandari, MBChB, FRCP, PhD, M Clin Edu, FHEA, Tasnim Momoniat, MBChB, MRCP (UK) and Duha Ilyas, MBBS, MRCP (UK)
    Cleveland Clinic Journal of Medicine January 2020, 87 (1) 9-10; DOI: https://doi.org/10.3949/ccjm.87c.01002
  • Off-label and oft-prescribed
    Brian F. Mandell, MD, PhD
    Cleveland Clinic Journal of Medicine December 2019, 86 (12) 766-767; DOI: https://doi.org/10.3949/ccjm.86b.12019

    When prescribing drugs for uses beyond their FDA indications, we need to explain their anticipated side effects and benefits.

  • How to respond to flu vaccine doubters
    Sherif Beniameen Mossad, MD, FACP, FIDSA, FAST
    Cleveland Clinic Journal of Medicine December 2019, 86 (12) 782-788; DOI: https://doi.org/10.3949/ccjm.86a.19139

    Misinformation and unfounded fears abound. What should you tell patients who say no to a fl u shot?

  • Beyond depression: Other uses for tricyclic antidepressants
    Joanne Schneider, DNP, RN, CNP, Mary Patterson, CNP and Xavier F. Jimenez, MD, MA
    Cleveland Clinic Journal of Medicine December 2019, 86 (12) 807-814; DOI: https://doi.org/10.3949/ccjm.86a.19005

    The pharmacology of these drugs, their potential uses in conditions other than depression, and safety considerations.

  • Gabapentin for alcohol use disorder: A good option, or cause for concern?
    Vania Modesto-Lowe, MD, MPH, Gregory C. Barron, MD, Benjamin Aronow, BS and Margaret Chaplin, MD
    Cleveland Clinic Journal of Medicine December 2019, 86 (12) 815-823; DOI: https://doi.org/10.3949/ccjm.86a.18128

    There is concern about the potential for abuse. Use it only as a second-line alternative, with caution.

Pages